Express Scripts offers option to cap insulin costs

As congressional pressure mounts on drug companies and PBMs over rising insulin costs, Express Scripts presented clients with a new option Wednesday that could lessen the burden on patients in the near term.

Express

Read the full 330 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE